Romilast 4 mg: Not for Children Under 12 – Safety Warning

Romilast (montelukast) 4 mg chewable tablets are approved for children ages 2–5 for asthma and allergic rhinitis. The 5 mg and 10 mg tablets are for older children and adults.

Critical: The 4 mg dose is not appropriate for a 2-year-old without a physician's specific prescription. Dosing is weight- and age-based. Giving an incorrect dose risks side effects (neuropsychiatric events, GI upset, headache) without therapeutic benefit.

If your child has respiratory symptoms, see a pediatrician for proper diagnosis and age-appropriate treatment. Never share or repurpose prescription medications.